Position in SCLX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$59,632
-$182,488 QoQ
Shares Held
14,380
-54.9% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $6,106,168,968 across 18 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,199,053 | $1,438,180,257 | |
| 2 | JNJ |
Johnson & Johnson
|
3,925,186 | $996,879,486 | |
| 3 | AZN |
Astrazeneca PLC
|
4,895,753 | $928,332,681 | |
| 4 | ABBV |
AbbVie Inc.
|
2,327,207 | $585,618,368 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,614,905 | $464,515,291 | |
| 6 | PFE |
Pfizer Inc
|
19,228,115 | $463,013,007 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,969,159 | $375,123,546 | |
| 8 | AMGN |
Amgen Inc
|
1,020,869 | $369,677,081 |
All Filings in SCLX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,632 | 8,954 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $242,120 | 19,846 | Shares | Defined | 2026-02-13 | |
| 2025-03-31 | $59,168 | 237,624 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $105,542 | 247,753 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $520,503 | 562,706 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $160,336 | 83,076 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $842,350 | 529,780 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $727,348 | 356,543 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $333,968 | 238,549 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $1,323,565 | 237,624 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $1,960,866 | 239,130 | Shares | Defined | 2023-05-11 | |
| No filing history on record for this holder in this stock. | ||||||